Recipharm’s new modular sterile filling system, specifically tailored for process development, pilot scale and clinical ...

Independent research institute BioMed X has completed its oncology research project in partnership with Merck, the data from ...

The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal ...

In December 2024, Novo Nordisk announced that the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings was completed.

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.

4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...